SITEMAP  |  CONTACT  |  GLOSSARY  |  
PULSION Medical System SE
Please choose your language:  USA (English)DeutschEspañolFrançaisBelgiumNetherlands
PULSION Medical System SE
PULSION Medical System AG

Press Releases

PULSION grows by 12 percent in first half of year

EBIT margin over 20% for first time / Free cash flow conversion at 67% /Outlook unchangedMunich, August 11, 2011 – PULSION Medical Systems SE is a life sciencecompany listed in the Prime Standard segment of the Frankfurt StockExchange and specializes in medical diagnosis and therapy systems. In...

(22.08.2011)
[more]
 
PULSION is becoming PULSION Medical Systems SE

Munich, June 10, 2011 - PULSION Medical Systems AG, Munich, a life-science corporation specializing in medical diagnosis and therapy systems, which is noted in the Prime Standard segment at the Frankfurt Stock Exchange, was converted into an European Corporation (Societas Europeae) on the basis of...

(14.06.2011)
[more]
 
PULSION Medical Systems AG passes resolution to buy back shares via the stock exchange

Munich, December 30, 2010 – The Management Board of  PULSION Medical Systems AG, Munich, ISIN DE0005487904 // WKN 548790, passed a resolution today to buy back up to 300,000 PULSION shares via the stock exchange. The corresponding shareholder and supervisory board authorizations are in place....

(12.01.2011)
[more]
 
PULSION Medical Systems AG raises buy-volume in conjunction with share buy-back

Munich, December 15, 2010 - The Management Board of PULSION Medical Systems AG, Munich, ISIN DE0005487904 // WKN 548790, has decided to raise the volume of shares to be bought back in conjunction with the Company’s share buy-back above the original level of 250,000 shares to 588,839 shares.In...

(16.12.2010)
[more]
 
PULSION Medical Systems AG provides further update on the share buy-back offer

Munich, December 08, 2010 - The Management Board of PULSION Medical Systems AG, Munich, ISIN DE0005487904 // WKN 548790, announces, that within the scope of the current public share buy-back offer there were registered 130.683 shares for buy-back as at December 08, 2010.The offer period ends on...

(09.12.2010)
[more]
 
 
print

Press contact

PULSION Medical Systems SE

Ralph Schaefer
Director Legal Affairs

Tel: +49 (0)89/ 45 99 14 211
Fax: +49 (0)89 / 45 99 14 481
E-Mail: schaefer@pulsion.com

Press Pictures

 
Imprint
Terms of use
 
 
by schrittmacher